Research ArticleCancer

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

See allHide authors and affiliations

Science Translational Medicine  08 Feb 2012:
Vol. 4, Issue 120, pp. 120ra17
DOI: 10.1126/scitranslmed.3003316

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article